Stay updated on Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial

Sign up to get notified when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2; no substantive changes to the study details or navigation are evident.
    Difference
    0.0%
    Check dated 2026-04-16T09:38:08.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added; 'Sjogren's Syndrome' resources were removed and the prior Revision: v3.4.3 marker was deleted.
    Difference
    0.1%
    Check dated 2026-03-25T19:59:59.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A new site revision entry v3.4.3 was added and v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T12:47:48.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    A minor site revision (v3.4.2) was added; the non-critical funding-status notice and a prior revision notice (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:43:55.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, warning that information may not be up to date and that transactions may not be processed, with a link to opm.gov. The page revision label was updated to v3.4.1 (removing v3.4.0).
    Difference
    0.3%
    Check dated 2026-02-03T23:53:22.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Show glossary added; QC-related 'Last Update Submitted that Met QC Criteria' field added; No FEAR Act Data disclosure added; page revision updated to v3.4.0. Previously shown items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision v3.3.4 were removed.
    Difference
    0.1%
    Check dated 2026-01-27T22:49:58.000Z thumbnail image

Stay in the know with updates to Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.